e-Cure
Board
2 directors, no change since 2023Director (not named in the articles)
since 28-06-2023
term without a fixed end
earlier manager, until 03-07-2023
listed in the 2026 annual accounts, filed on 29-10-2026
Director (not named in the articles)
since 28-06-2023
term without a fixed end
listed in the 2026 annual accounts, filed on 29-10-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 03-07-2023
Mandates through the years
2 names, the dashed line is todayDirector (not named in the articles)
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Manager (not named in the articles), appointed by deed of 20-11-2013, until 03-07-2023
- Director (not named in the articles), since before 03-07-2023
-
- Director (not named in the articles), since before 31-03-2023
With Starter you also see 1 former office holder in the mandate history.
See the plans →
Control
Founders
, ,
This company
e-Cure
Equity €117,530
Profit €37,163 in 2026
Capital
- Contribution
- €18,600
- Shares
- 186
- Contribution per share
- €100
- Equity per share
- €632 in 2026
- Source
- 2026 annual accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 20-11-2013 (in Dutch)
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 directordeed of 03-07-2023 (in Dutch)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of August at 18:00deed of 03-07-2023 (in Dutch)
Founders
At incorporation
deed of 20-11-2013 ↗
- founder
- founder
- founder
Capital transactions
Capital over time
- 03-07-2023 Converted to unavailable equity · €20,460
- 20-11-2013 Incorporation · €18,600 · 186 shares